Search Results 731-740 of 16332 for monoclonal antibody

1. A Study of the Safety and Drug/Body Interactions of BGB-3111 for Patients with B-Cell Lymphoid Malignancies - Mayo Clinic

   Monoclonal antibody within 4 weeks. Not recovered from toxicity of any prior chemotherapy to grade ≤ 1. History of other active malignancies within 2 years ...

2. Clinical trials - Oncology (Medical)

   Monoclonal antibodies, such as rituximab, may block cancer growth in different ways by targeting certain cells. Romidepsin and lenalidomide may stop the ...

3. Publications - Pablo Moreno Franco, M.D. - Mayo Clinic

   ... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Shah SZ, Alvarez FG, Sanghavi ...

4. MAYO MAGAZINE - Autumn 2008 - MC2386-AU08

   “BEXXAR is an intravenous monoclonal antibody that's directed against the proteins located ... Monoclonal antibodies identify the bad cancer cells and ...

5. Myeloma, Amyloidosis, Dysproteinemia Group - Overview - Mayo Clinic

   Monoclonal gammopathy-associated conditions including C1-esterase inhibitor deficiency, cryoglobulinemia, osteosclerotic myeloma, peripheral neuropathy ...

6. A Study of LY2951742 in Participants With Chronic Cluster Headache - Mayo Clinic

   Known hypersensitivity to multiple drugs, monoclonal antibodies or other therapeutic proteins. A history or presence of other medical illness that indicates ...

7. Mononucleosis - Diagnosis & treatment - Mayo Clinic

   Antibody tests. If there's a need for additional confirmation, a monospot test may be done to check your blood for antibodies to the Epstein-Barr virus.

8. A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia - Mayo Clinic

   Severe infection or inflammation at the time of Screening. 2. History of clinically significant hypersensitivity associated with monoclonal antibody

9. A Study of the Use of Pembrolizumab (MK-3475) in Patients with Relapsed or Hard to Treat Classical Hodgkin Lymphoma - Mayo Clinic

   Prior monoclonal antibody within 4 weeks prior to study Day 1; Prior Chemotherapy, targeted small molecular therapy, or radiation therapy within 2 weeks ...

10. Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma

    ... monoclonal antibody and an immunomodulatory drug. * Must be naïve to treatment with ABBV-383. Exclusion Criteria: - Received B-cell maturation antigen (BCMA) ...